Ard, J., Fitch, A., Fruh, S., et al
Both of these medications contain semaglutide GLP-1, a powerful aid in weight loss that works by mimicking the hormone glucagon-like peptide-1 (GLP-1), which helps regulate appetite and food intake
What youll learn: Ozempic and metformin are both approved for managing type 2 diabetes, but can be prescribed off-label for weight loss
If you spend 10 weeks microdosing before reaching 2.5 to 5 mg, your results over 72 total weeks may be modestly lower due to the delayed therapeutic onset, but adherence benefits may compensate
Indeed, eGFR values were greater in patients on tirzepatide compared to those on insulin glargine, with a mean eGFR decline rate of 1.4 ml/min/1.73 m 2 per year in tirzepatide users and a between-group difference in eGFR reduction of 2.2 ml/min/1.73 m 2 per year [49]
Read source Wharton, S., et al